0000-0002-6714-141X Employment
-
Inova Schar Cancer Institute Clinical Program Director of Genitourinary Cancers2015 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (220)
- Impact of Age on Outcomes in Metastatic Non–Clear Cell Renal Cell Carcinoma: A Real-World TriNetX Analysis from the Global Society of Rare Genitourinary Tumors (GSRGT) Save
- Current poly(adenosine diphosphate–ribose) polymerase inhibitors (PARPi) in metastatic prostate cancer: uses and controversies Save
- Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial Save
- Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in patients with high body mass index or diabetes mellitus Save
- Tumor-Informed Circulating Tumor DNA (ctDNA) in Locally Advanced and Metastatic Urothelial Carcinoma: A Retrospective Single-Center Cohort Save
- Same-Day Multidisciplinary Clinics for Patients With Newly Diagnosed Adult Solid Tumor Cancer: A Systematic Review Save
- National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations Save
- The role of HER2-targeted therapy in urothelial carcinomas Save
- Data from Real-world Data on Risk Factors for Emergency Department Visits to Treat Outpatient Chemotherapy-Associated Toxicities Save
- Figure 1 from Real-world Data on Risk Factors for Emergency Department Visits to Treat Outpatient Chemotherapy-Associated Toxicities Save